Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
The deadline to sign up for the Affordable Care Act ends on Sunday.
Sweden has discovered what is believed to be Europe's biggest deposit of rare earth metals.
Woman checks out at a grocery store. Credit: Luis Alvarez via Getty Images
Vaccination rates have dropped again among U.S. kindergarteners.
The Pentagon has now received 510 reports of unidentified flying objects. Many of those reports, 366, were added to the total in just the last two years. The other 144 sightings were reported over a 17-year period.
Thousands of New York City nurses are back at work after a strike ended at two of the city's biggest hospitals.
More than a dozen states have now banned substances known as "forever chemicals."
A new study by Columbia University Irving Medical Center said evidence suggests that prolonged sitting has detrimental effects on one's well-being but there is a fix.
Russia is planning a rescue mission to bring home three crewmembers in orbit.
A study says a five-minute light walk can alleviate the effects of sitting at a desk all day.
